Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia

Bibliographic Details
Title: Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia
Authors: Luo, Meng-Xiao 1, 2, Tan, Tania 1, 2, Trussart, Marie 1, 2, Poch, Annika 2, 3, Nguyen, Thi Minh Hanh 2, 3, Speed, Terence P. 1, 2, Hicks, Damien G. 4, Bandala-Sanchez, Esther 1, 2, Peng, Hongke 1, 2, Chappaz, Stéphane 5, Slade, Charlotte 1, 2, Utzschneider, Daniel T. 2, 3, Koldej, Rachel M. 2, 6, Ritchie, David 2, 6, 7, Strasser, Andreas 1, 2, Thijssen, Rachel 1, 2, Ritchie, Matthew E. 1, 2, Tam, Constantine S. 5, 8, Lindeman, Geoffrey J. 1, 2, 9, Huang, David C. S. 1, 2, Lew, Thomas E. 1, 2, 7, 9, Anderson, Mary Ann 1, 2, 7, 9, Roberts, Andrew W. 1, 2, 7, 9, Teh, Charis E. 1, 2, ∗, Gray, Daniel H. D. 1, 2, ∗∗
Source: In Blood 26 December 2024 144(26):2748-2761
Database: ScienceDirect
More Details
ISSN:00064971
DOI:10.1182/blood.2024024341
Published in:Blood
Language:English